Tuesday, February 07, 2012
Torrey Pines could begin human testing of new pain medication in 2013

The drug would be a breakthrough in pain medication at a time when state and local legislators are trying to curb addiction to prescription drugs. The drug is designed to provide quick pain relief while eliminating side effects such as addiction, respiratory depression and adverse psychological consequences. ..

Read More
Thursday, January 19, 2012
Researchers moving nearer solutions for greening disease

Situated on a piece of unexceptional land between I-95 and Florida’s Turnpike west of Ft. Pierce, Fla., many of the 150 USDA/Agricultural Research Service staffers and scientists working here focus on saving the citrus industry from destruction by citrus greening disease. They realize they’re in a race against time. They think they are edging ever closer to winning. ..

Read More
Monday, October 10, 2011
Dr. Lawrence Toll Receives $1.8 million Grant for Pain Drug Discovery

Dr. Lawrence Toll, Full Member and Director of Neuropharmacology at Torrey Pines Institute for Molecular Studies will study potential treatments for acute and chronic pain with reduced addiction, thanks to a 5 year, $1.86 million grant awarded by the National Institute on Drug Abuse. ..

Read More
Monday, September 19, 2011
Torrey Pines Institute receives $360,000 grant for lung cancer research

Dmitriy Minond, assistant member, cancer research, at Torrey Pines Institute for Molecular Studies in Port St. Lucie will research selective inhibitors that can be used in lung cancer research and therapy, thanks to a three-year, $360,000 grant awarded by the Florida Department of Health and the James & Esther King Biomedical Research Program. ..

Read More
Wednesday, August 17, 2011
Dr. Houghten Receives $2.3 million Grant for the Discovery of New Pain Killers

Dr. Richard A. Houghten, Founder, President & CEO of Torrey Pines Institute for Molecular Studies will utilize a new methodology that may accelerate drug discovery in multiple therapeutic areas like pain management, thanks to a 5-year, $2.34 million grant awarded by the National Institute on Drug Abuse.

Read more... ..

Read More
Friday, August 12, 2011
Dr. Richard Houghten Receives Highest Rotary Award

Torrey Pines Institute Founder, President and CEO Richard Houghten, Ph.D. received the Rotary Club’s highest honor, the Paul Harris Award. The honor recognizes the role Dr. Houghten and Torrey Pines Institute have played in St. Lucie County, particularly the Institute’s contributions to advancement in the community.
Read more... ..

Read More
Thursday, July 28, 2011
Dr. Jay McLaughlin receives $2.2 million grant for HIV-related Mood Disorders

Dr. Jay McLaughlin, Associate Member, Pharmacology and Neuroscience at Torrey Pines Institute for Molecular Studies will study how the HIV virus produces related neuropathology and mood disorders, thanks to a 5 year, $2.23 million grant awarded by the National Institute of Mental Health. ..

Read More
Wednesday, June 29, 2011
RxMD Announces Development Collaboration with GlycoRegImmune Inc.

RxMD, Inc., a privately-held, global therapeutics development company, today announced a collaboration agreement with GlycoRegImmune Inc. (GRI) to develop new treatments for inflammatory, autoimmune, and neurodegenerative conditions based on GRI's novel natural killer (NK) T cell targeted technologies. ..

Read More
Tuesday, March 01, 2011
Commentary: Biotech hub takes off as scientific advances bubble up

Two years ago this month, Scripps Florida dedicated its remarkable new campus facilities in Jupiter. The event was a ray of sunshine in a dark economy. ..

Read More
Tuesday, March 01, 2011
Torrey Pines scientist using sea creatures in research aimed at combating tobacco addiction

One local scientist's research with underwater snails could make it easier to quit smoking. ..

Read More